<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: There is increasing evidence suggesting that <z:e sem="disease" ids="C0041234" disease_type="Disease or Syndrome" abbrv="">Chagas disease</z:e> involves oxidative damage and contributes to <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> progression </plain></SENT>
<SENT sid="1" pm="."><plain>OBJECTIVE: To evaluate the effect of <z:chebi fb="0" ids="3441">carvedilol</z:chebi> on <z:mp ids='MP_0003674'>oxidative stress</z:mp> markers in <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0041234" disease_type="Disease or Syndrome" abbrv="">Chagas disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The study population included 42 patients with Chagas <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> and <z:mp ids='MP_0003674'>oxidative stress</z:mp> biomarkers were measured before and after a period of six months of treatment with <z:chebi fb="0" ids="3441">carvedilol</z:chebi> (37.5 mg/day) </plain></SENT>
<SENT sid="3" pm="."><plain>Patients were considered according to the Los Andes classification and the activity of <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase, catalase, <z:chebi fb="0" ids="16856">glutathione</z:chebi> peroxidase, S-transferase and reductase, myeloperoxidase and <z:chebi fb="3" ids="16335">adenosine</z:chebi> deaminase; levels of reduced <z:chebi fb="0" ids="16856">glutathione</z:chebi>, <z:chebi fb="0" ids="33202">thiobarbituric acid</z:chebi> reactive species, <z:chebi fb="1" ids="23019">carbonyl</z:chebi> protein, vitamin E and nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> were measured in blood </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: After treatment with <z:chebi fb="0" ids="3441">carvedilol</z:chebi>, <z:hpo ids='HP_0000001'>all</z:hpo> groups showed significant reductions in levels of <z:chebi fb="1" ids="23019">carbonyl</z:chebi> protein and reduced <z:chebi fb="0" ids="16856">glutathione</z:chebi>, whereas the levels of nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> and <z:chebi fb="3" ids="16335">adenosine</z:chebi> activity increased significantly only in group IA </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, most of the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzymes showed decrease in activity in groups IA and IB </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: The data suggest that treatment with <z:chebi fb="0" ids="3441">carvedilol</z:chebi> was effective in attenuating oxidative damage, an effect that may be particularly important in patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0041234" disease_type="Disease or Syndrome" abbrv="">Chagas' disease</z:e> <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
</text></document>